Translocation of non-natural chemical entities through anthrax protective antigen pore
US-9498538-B2 · Nov 22, 2016 · US
US2016252522A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016252522-A1 |
| Application number | US-201615063774-A |
| Country | US |
| Kind code | A1 |
| Filing date | Mar 8, 2016 |
| Priority date | Sep 9, 2013 |
| Publication date | Sep 1, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of proteolyzing a protein, including immobilizing a protein in at least one pore of a porous body, and contacting the protein immobilized in the pore and a protease immobilized on a solid surface such that the protease selectively accesses a site of the protein and proteolyzes the protein at the site.
Opening claim text (preview).
What is claimed is: 1 . A method of proteolyzing a protein, comprising: immobilizing a protein in at least one pore of a porous body; and contacting the protein immobilized in the pore and a protease immobilized on a solid surface such that the protease selectively accesses a site of the protein and proteolyzes the protein at the site. 2 . The method of claim 1 , wherein the solid surface is a surface of at least one particle. 3 . The method of claim 2 , wherein the at least one pore is a plurality of pores, the at least one particle is a plurality of particles, and the plurality of particles has an average particle diameter larger than an average pore diameter of the plurality of pores. 4 . The method of claim 3 , wherein the contacting is performed in a liquid. 5 . The method of claim 1 , wherein the immobilizing comprises immobilizing the protein at a site different from the site of the protein at which the protein is proteolyzed. 6 . The method of claim 1 , wherein the immobilizing comprises immobilizing the protein in the pore through a linker molecule that site-specifically interacts with the protein. 7 . The method of claim 6 , wherein the immobilizing is performed such that the protein having the linker molecule bound thereto has a molecular size which is 0.5 times to 1.5 times greater than the average pore diameter of the pores. 8 . The method of claim 2 , wherein the protease is immobilized on the surface of the particle through a spacer molecule that binds with the protease. 9 . The method of claim 1 , wherein the protein is an antibody. 10 . The method of claim 9 , wherein the antibody is a monoclonal antibody. 11 . The method of claim 4 , wherein the protein is an antibody. 12 . The method of claim 11 , wherein the antibody is a monoclonal antibody. 13 . The method of claim 9 , wherein the immobilizing comprises immobilizing an Fc domain of the antibody, and the contacting is performed such that a Fab domain of the antibody is site-selectively proteolyzed by the protease. 14 . The method of claim 11 , wherein the immobilizing comprises immobilizing an Fc domain of the antibody, and contacting is performed such that a Fab domain of the antibody is site-selectively proteolyzed by the protease. 15 . The method of claim 1 , wherein the protease is trypsin. 16 . The method of claim 4 , wherein the protease is trypsin. 17 . The method of claim 4 , wherein the average particle diameter of the particles is 100 nm or greater and the average pore diameter of the pores is in a range of from 30 nm to 150 nm, provided that the average particle diameter is larger than the average pore diameter. 18 . The method of claim 11 , wherein the average particle diameter of the particles is 120 nm or greater, and the average pore diameter of the pores is in a range of from 50 nm to 100 nm. 19 . The method of claim 18 , wherein the average particle diameter of the particles is 150 nm or greater. 20 . The method of claim 18 , wherein the average particle diameter of the particles is 170 nm or greater. 21 . The method of claim 18 , wherein the average particle diameter of the particles is in a range of from 120 nm to 1 μm. 22 . The method of claim 20 , wherein the average particle diameter of the particles is in a range of from 170 nm to 300 nm. 23 . A kit for proteolyzing a protein, comprising: at least one porous body having a plurality of pores in which a protein is to be immobilized; and a plurality of particles having an average particle diameter larger than an average pore diameter of the pores, wherein the particles have a surface on which a protease has been immobilized or to be immobilized. 24 . The kit of claim 23 , wherein the particles have a protease immobilized on the surface of the particles. 25 . The kit of claim 23 , wherein the average particle diameter of the particles is 100 nm or greater and the average pore diameter of the pores in the porous body is in a range of from 30 nm to 150 nm, provided that the average particle diameter is larger than the average pore diameter. 26 . A method of quantitating a protein in a sample, comprising: proteolyzing a protein in a sample by the method of claim 1 such that a plurality of peptide fragments including a peptide fragment specific to the protein are produced from the protein; and subjecting the peptide fragments to a mass spectrometric analysis to detect the peptide fragment. 27 . The method of claim 26 , wherein the protein is an antibody, and the peptide fragments include at least a portion of an amino acid sequence of a complementarity determining region of the antibody.
by hydrolysis {, i.e. solvolysis in general} · CPC title
by chemical modification of precursor peptides · CPC title
by adsorption or absorption · CPC title
Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof · CPC title
Antibody fragments · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.